Werner Henrich was born 1943 and is a French citizen. His educational background is as a chemist and European patent attorney.Werner worked for F. Hoffmann-La Roche Ltd in Basel for more than 30 years, where he held various positions, including Head of Global Intellectual Property and Pharmaceutical Licensing for more than 12 years. He was also a member of the Roche Pharmaceutical Division Executive Board. He retired from Roche in November 2003. Werner has wide experience in the pharmaceutical industry, both with start-ups and large pharmaceutical companies.In 2010, Werner contributed, as its Chairman, to the acquisition of Preglem in Geneva by Gedeon Richter. Werner was Chairman of the board of Basilea Pharmaceutica Ltd until April 2013.Werner is a member of the board of directors of Actelion Ltd, Allschwil and Addex Pharmaceuticals Ltd, Geneva, both Swiss biopharmaceutical companies listed on the SWX Swiss Exchange.